Author's details
- Dr Saidat O. OLOKO
- (FMCFM, MPH)
Reviewer's details
- Dr Akinyele Akinlade
- MBBS, FWACP, FACE
- Hospital Odan, Lagos. Deputy MD and the HOD Medicine
- Date Uploaded: 2025-03-19
- Date Updated: 2025-03-19
Hypertension
Hypertension, or high blood pressure, is characterized by consistently elevated pressure against the artery walls, defined by the Eighth Joint National Committee (JNC 8) as a systolic blood pressure (SBP) of 140 mm Hg or higher, or a diastolic blood pressure (DBP) of 90 mm Hg or higher. The condition results from a complex interplay of genetic, environmental, and physiological factors that increase vascular resistance and, in some cases, cardiac output.
Key mechanisms include the overactivation of the Renin-Angiotensin-Aldosterone System (RAAS), which leads to vasoconstriction and sodium retention; heightened activity of the Sympathetic Nervous System (SNS), causing further vasoconstriction and increased heart rate; vascular remodeling, in which chronic high blood pressure induces structural changes in blood vessel walls; and endothelial dysfunction, which impairs the production of vasodilators like nitric oxide, promoting vasoconstriction.
In resource-poor settings, hypertension is often underdiagnosed and undertreated due to limited healthcare access, cultural beliefs, and low awareness. Effective management requires culturally sensitive education, better healthcare access, and community-driven BP monitoring for early detection.
Hypertension is often asymptomatic, earning its reputation as the “silent killer.” When symptoms occur, they may indicate severe hypertension or organ damage, presenting as morning occipital headaches, dizziness, blurred vision, nosebleeds, shortness of breath, palpitations, fatigue, or confusion. In hypertensive emergencies (≥180/120 mmHg), symptoms can escalate to chest pain, severe headaches, nausea, vomiting, seizures, or altered consciousness, requiring urgent medical attention. Since symptoms are unreliable indicators, routine blood pressure monitoring is essential for early detection and prevention of complications.
Hypertension assessment confirms diagnosis, evaluates severity, detects complications, and identifies secondary causes, especially in resource-limited settings where late presentation is common.
Blood pressure patterns vary: sustained hypertension (persistently elevated BP), masked hypertension (normal in clinic, high at home—common in young adults, diabetics, and chronic kidney disease patients), and white coat hypertension (high in clinic, normal at home). Home monitoring (and 24-hour ambulatory BP monitoring if available) helps differentiate these cases.
General examination may reveal central obesity, moon facies (in Cushing’s syndrome), pallor (CKD/anaemia), sweating and tremors (pheochromocytoma/hyperthyroidism), xanthelasma (dyslipidaemia), or oedema (renal or cardiac involvement).
Cardiovascular findings include radio femoral delay (coarctation), bounding pulses (aortic regurgitation), thickened arterial walls (atherosclerosis), weak pulses (peripheral arterial disease), and a >20 mmHg BP difference between arms (aortic dissection). Heart sounds (loud S2, S4 gallop) suggest left ventricular hypertrophy, while carotid bruits indicate (atherosclerosis and increased) stroke risk.
Fundoscopy detects hypertensive retinopathy, ranging from arteriolar narrowing to papilledema in severe cases. Neurological signs include stroke-related deficits or cognitive impairment from chronic hypertension.
Early detection through home BP monitoring, cardiovascular assessment, and fundoscopy is crucial, especially where advanced diagnostics are limited.
Hypertension can be primary or secondary. Primary (essential) hypertension is a diagnosis of exclusion, often asymptomatic unless complications arise, and common in middle-aged adults with risk factors like genetics, obesity, and high salt intake. Secondary hypertension should be suspected in cases of abrupt onset, age <30 or >55, resistance to multiple drugs, or disproportionate end-organ damage.
Common secondary causes include:
- Renal parenchymal disease (proteinuria, abnormal creatinine)
- Renovascular hypertension (abdominal bruit, flash pulmonary oedema, worsening renal function with ACEIs/ARBs)
- Endocrine disorders: Primary aldosteronism (hypokalaemia), Cushing’s syndrome (central obesity, striae), pheochromocytoma (episodic headaches, palpitations), thyroid dysfunction (tachycardia or bradycardia)
- Coarctation of the aorta (upper limb hypertension with weak femoral pulses)
- Obstructive sleep apnoea (snoring, daytime somnolence)
- Drug-induced hypertension (NSAIDs, steroids, oral contraceptives, central stimulants found in ADHD medicines or illicit drugs abuse)
- Pregnancy-related hypertension (gestational hypertension, preeclampsia, eclampsia)
A detailed history, physical examination, and targeted investigations help differentiate these causes, with referral for suspected secondary hypertension when necessary.
Hypertension is diagnosed based on office BP readings ≥140/90 mmHg on two separate visits or home BP ≥135/85 mmHg. Routine tests include:
- Urinalysis for proteinuria
- Serum electrolytes & creatinine for kidney function and suspected primary aldosteronism if there is hypokalemia
- Fasting blood glucose/HbA1c for diabetes
- Lipid profile for cardiovascular risk assessment
- ECG for left ventricular hypertrophy and ischemic changes
Additional tests like renal ultrasound, aldosterone-renin ratio, 24-hour urinary metanephrines, thyroid function tests, and echocardiography may be needed for suspected secondary hypertension.
Lifestyle Modifications
- Salt intake <5g/day
- DASH diet rich in fruits, vegetables, and lean protein
- Exercise (≥150 minutes weekly)
- Weight control
- Smoking and alcohol cessation
Pharmacologic Therapy
First-line medications:
- ACE inhibitors/ARBs (for diabetics and CKD patients)
- Calcium channel blockers (for black patients and the elderly)
- Thiazide diuretics (for volume control)
Second-line agents:
- Beta-blockers (for heart disease)
- Spironolactone (for resistant cases, where primary aldosteronism is suspected)
- Alpha-blockers (for patients with BPH)
Referral is necessary for resistant hypertension, suspected secondary hypertension, or hypertensive emergencies (≥180/120 mmHg with organ damage).
Patients should have BP monitored every 2-4 weeks initially, then every 3-6 months once stable, with annual screenings for complications. Prevention efforts focus on lifestyle modifications, community screening, and patient education. Excess salt intake, common in African diets, should be reduced through fresh ingredients and natural spices.
For diagnosed patients, adherence to treatment is crucial, though many discontinue medications due to cost, lack of symptoms, or misconceptions. Patient-centered care, affordability-based drug selection, and regular monitoring for organ damage are key. In resource-limited settings, primary care providers and community health workers should be trained to manage uncomplicated cases.
Case Study: Overcoming Barriers to Hypertension Management
A middle-aged trader diagnosed during a community screening, dismissed hospital referral, relying instead on herbal remedies. Six months later, she presented with headaches and a BP of 180/100 mmHg. Initially treated with Amlodipine and Losartan, poor adherence due to financial constraints led to fluctuating BP levels. Her regimen was modified to a more affordable alternative (Amiloride/hydrochlorthiazide), and she received counselling on medication adherence and lifestyle changes. This case highlights the need for awareness, affordable treatment, and ongoing education to improve hypertension control in resource-poor settings.
- Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/AHA hypertension guidelines. Hypertension [Internet]. 2018 [cited 2025 Mar 17];71(6):e13-e115. Available from: https://doi.org/10.1161/HYP.0000000000000065
- Williams B, Mancia G, Spiering W, et al. 2018 ESC/ESH guidelines for the management of arterial hypertension. Eur Heart J [Internet]. 2018 [cited 2025 Mar 17];39(33):3021-3104. Available from: https://doi.org/10.1093/eurheartj/ehy339
- Mills KT, Stefanescu A, He J. The global epidemiology of hypertension. Nat Rev Nephrol [Internet]. 2020 [cited 2025 Mar 17];16(4):223-237. Available from: https://doi.org/10.1038/s41581-019-0244-2
- Assah FK, Ekelund U, Brage S, et al. Urbanization, physical activity, and metabolic health in Sub-Saharan Africa. Diabetes Care [Internet]. 2011 [cited 2025 Mar 17];34(2):491-496. Available from: https://doi.org/10.2337/dc10-0990
- Hamer M, Bruwer EJ, de Ridder JH, et al. The association between seven-day objectively measured habitual physical activity and 24-hour ambulatory blood pressure: the SABPA study. J Hum Hypertens [Internet]. 2017 [cited 2025 Mar 17];31(6):409-414. Available from: https://doi.org/10.1038/jhh.2016.93
- Piercy KL, Troiano RP, Ballard RM, et al. The Physical Activity Guidelines for Americans. JAMA [Internet]. 2018 [cited 2025 Mar 17];320(19):2020-2028. Available from: https://doi.org/10.1001/jama.2018.14854
- Carey RM, Muntner P, Bosworth HB, Whelton PK. Prevention and control of hypertension. J Am Coll Cardiol [Internet]. 2018 [cited 2025 Mar 17];72(11):1278-1293. Available from: https://doi.org/10.1016/j.jacc.2018.07.008
- Wright JT, Williamson JD, Whelton PK, et al. A randomized trial of intensive vs. Standard blood-pressure control. N Engl J Med [Internet]. 2015 [cited 2025 Mar 17];373(22):2103-2116. Available from: https://doi.org/10.1056/NEJMoa1511939

Author's details
Reviewer's details
Hypertension
- Background
- Symptoms
- Clinical findings
- Differential diagnosis
- Investigations
- Treatment
- Follow-up
- Prevention and control
- Further readings
Hypertension, or high blood pressure, is characterized by consistently elevated pressure against the artery walls, defined by the Eighth Joint National Committee (JNC 8) as a systolic blood pressure (SBP) of 140 mm Hg or higher, or a diastolic blood pressure (DBP) of 90 mm Hg or higher. The condition results from a complex interplay of genetic, environmental, and physiological factors that increase vascular resistance and, in some cases, cardiac output.
Key mechanisms include the overactivation of the Renin-Angiotensin-Aldosterone System (RAAS), which leads to vasoconstriction and sodium retention; heightened activity of the Sympathetic Nervous System (SNS), causing further vasoconstriction and increased heart rate; vascular remodeling, in which chronic high blood pressure induces structural changes in blood vessel walls; and endothelial dysfunction, which impairs the production of vasodilators like nitric oxide, promoting vasoconstriction.
In resource-poor settings, hypertension is often underdiagnosed and undertreated due to limited healthcare access, cultural beliefs, and low awareness. Effective management requires culturally sensitive education, better healthcare access, and community-driven BP monitoring for early detection.
- Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/AHA hypertension guidelines. Hypertension [Internet]. 2018 [cited 2025 Mar 17];71(6):e13-e115. Available from: https://doi.org/10.1161/HYP.0000000000000065
- Williams B, Mancia G, Spiering W, et al. 2018 ESC/ESH guidelines for the management of arterial hypertension. Eur Heart J [Internet]. 2018 [cited 2025 Mar 17];39(33):3021-3104. Available from: https://doi.org/10.1093/eurheartj/ehy339
- Mills KT, Stefanescu A, He J. The global epidemiology of hypertension. Nat Rev Nephrol [Internet]. 2020 [cited 2025 Mar 17];16(4):223-237. Available from: https://doi.org/10.1038/s41581-019-0244-2
- Assah FK, Ekelund U, Brage S, et al. Urbanization, physical activity, and metabolic health in Sub-Saharan Africa. Diabetes Care [Internet]. 2011 [cited 2025 Mar 17];34(2):491-496. Available from: https://doi.org/10.2337/dc10-0990
- Hamer M, Bruwer EJ, de Ridder JH, et al. The association between seven-day objectively measured habitual physical activity and 24-hour ambulatory blood pressure: the SABPA study. J Hum Hypertens [Internet]. 2017 [cited 2025 Mar 17];31(6):409-414. Available from: https://doi.org/10.1038/jhh.2016.93
- Piercy KL, Troiano RP, Ballard RM, et al. The Physical Activity Guidelines for Americans. JAMA [Internet]. 2018 [cited 2025 Mar 17];320(19):2020-2028. Available from: https://doi.org/10.1001/jama.2018.14854
- Carey RM, Muntner P, Bosworth HB, Whelton PK. Prevention and control of hypertension. J Am Coll Cardiol [Internet]. 2018 [cited 2025 Mar 17];72(11):1278-1293. Available from: https://doi.org/10.1016/j.jacc.2018.07.008
- Wright JT, Williamson JD, Whelton PK, et al. A randomized trial of intensive vs. Standard blood-pressure control. N Engl J Med [Internet]. 2015 [cited 2025 Mar 17];373(22):2103-2116. Available from: https://doi.org/10.1056/NEJMoa1511939

Content
Author's details
Reviewer's details
Hypertension
Background
Hypertension, or high blood pressure, is characterized by consistently elevated pressure against the artery walls, defined by the Eighth Joint National Committee (JNC 8) as a systolic blood pressure (SBP) of 140 mm Hg or higher, or a diastolic blood pressure (DBP) of 90 mm Hg or higher. The condition results from a complex interplay of genetic, environmental, and physiological factors that increase vascular resistance and, in some cases, cardiac output.
Key mechanisms include the overactivation of the Renin-Angiotensin-Aldosterone System (RAAS), which leads to vasoconstriction and sodium retention; heightened activity of the Sympathetic Nervous System (SNS), causing further vasoconstriction and increased heart rate; vascular remodeling, in which chronic high blood pressure induces structural changes in blood vessel walls; and endothelial dysfunction, which impairs the production of vasodilators like nitric oxide, promoting vasoconstriction.
In resource-poor settings, hypertension is often underdiagnosed and undertreated due to limited healthcare access, cultural beliefs, and low awareness. Effective management requires culturally sensitive education, better healthcare access, and community-driven BP monitoring for early detection.
Further readings
- Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/AHA hypertension guidelines. Hypertension [Internet]. 2018 [cited 2025 Mar 17];71(6):e13-e115. Available from: https://doi.org/10.1161/HYP.0000000000000065
- Williams B, Mancia G, Spiering W, et al. 2018 ESC/ESH guidelines for the management of arterial hypertension. Eur Heart J [Internet]. 2018 [cited 2025 Mar 17];39(33):3021-3104. Available from: https://doi.org/10.1093/eurheartj/ehy339
- Mills KT, Stefanescu A, He J. The global epidemiology of hypertension. Nat Rev Nephrol [Internet]. 2020 [cited 2025 Mar 17];16(4):223-237. Available from: https://doi.org/10.1038/s41581-019-0244-2
- Assah FK, Ekelund U, Brage S, et al. Urbanization, physical activity, and metabolic health in Sub-Saharan Africa. Diabetes Care [Internet]. 2011 [cited 2025 Mar 17];34(2):491-496. Available from: https://doi.org/10.2337/dc10-0990
- Hamer M, Bruwer EJ, de Ridder JH, et al. The association between seven-day objectively measured habitual physical activity and 24-hour ambulatory blood pressure: the SABPA study. J Hum Hypertens [Internet]. 2017 [cited 2025 Mar 17];31(6):409-414. Available from: https://doi.org/10.1038/jhh.2016.93
- Piercy KL, Troiano RP, Ballard RM, et al. The Physical Activity Guidelines for Americans. JAMA [Internet]. 2018 [cited 2025 Mar 17];320(19):2020-2028. Available from: https://doi.org/10.1001/jama.2018.14854
- Carey RM, Muntner P, Bosworth HB, Whelton PK. Prevention and control of hypertension. J Am Coll Cardiol [Internet]. 2018 [cited 2025 Mar 17];72(11):1278-1293. Available from: https://doi.org/10.1016/j.jacc.2018.07.008
- Wright JT, Williamson JD, Whelton PK, et al. A randomized trial of intensive vs. Standard blood-pressure control. N Engl J Med [Internet]. 2015 [cited 2025 Mar 17];373(22):2103-2116. Available from: https://doi.org/10.1056/NEJMoa1511939
Advertisement
